Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers
Elizabeth Page(Institute of Cancer Research), Manuel R. Teixeira(Instituto Português de Oncologia Francisco Gentil), Hans F. A. Vasen(Leiden University Medical Center), Paul A. James(The Royal Melbourne Hospital), Lyon Mascarenhas(Peter MacCallum Cancer Centre), Wendy van Zelst-Stams(Radboud University Nijmegen), Sarah Thomas(King's College London), Mona Hassan Al Battat(Lund University), Joanne McKinley(Peter MacCallum Cancer Centre), Derek J. Rosario(Royal Hallamshire Hospital), Anthony Chamberlain(Institute of Cancer Research), Louise Taylor(Royal Marsden NHS Foundation Trust), Palle Jørn Sloth Osther(University of Southern Denmark), Eli Marie Grindedal(Oslo University Hospital), Kai‐Ren Ong(Birmingham Women's Hospital), Thomas D. Jensen(Vejle Sygehus), Louise Izatt(Guy's and St Thomas' NHS Foundation Trust), Margreet G.E.M. Ausems(McGill University Health Centre), Melissa Assel(Memorial Sloan Kettering Cancer Center), Janneke Ringelberg(Hereditary Disease Foundation), Christi J. van Asperen(Loyola University Medical Center), Lambertus A. Kiemeney(Radboud University Nijmegen), Jimmy Lam(Flinders Medical Centre), Lucy Side(Unknown), Mark N. Brook(Institute of Cancer Research), Karen O’Toole(University of Utah), Susan M. Domchek(University City Science Center), Holly Ní Raghallaigh(Institute of Cancer Research), Dominika Wokołorczyk(International Hereditary Cancer Center), Saundra S. Buys(University of Utah), Vishakha Tripathi(Guy's and St Thomas' NHS Foundation Trust), Elena Genova(NorthShore University HealthSystem), Lídia Feliubadaló(University of Cologne), Lovise Mæhle(Unknown), Cezary Cybulski(International Hereditary Cancer Center), D. Gareth Evans(Manchester Academic Health Science Centre), Camilla Huber(Birmingham Women's Hospital), Jacquelyn M. Powers(Texas Children's Hospital), Rogier A. Oldenburg(Erasmus MC), Jennifer Pope(Institute of Cancer Research), Brian T. Helfand(NorthShore University HealthSystem), Jan C. Oosterwijk(University Medical Center Groningen), Tessy Thomas(Princess Anne Hospital), Jeanette Rothwell(Manchester Academic Health Science Centre), Rita K. Schmutzler(University of Cologne), Natalie Taylor(Royal Marsden NHS Foundation Trust), Mónica Salinas(Institut d'Investigació Biomédica de Bellvitge), Elizabeth Bancroft(Royal Marsden NHS Foundation Trust), Kerstin Rhiem(University Hospital Cologne), Jackie Cook(Sheffield Children's Hospital)
Cited by 239
Related Papers
Common variants conferring risk of schizophrenia
|Nature|2009|1.7k
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation
|Journal of Clinical Oncology|2014|1.7k